{
  "id": 6285267,
  "title": "Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff",
  "url": "https://urgent.news/2026/09/08/novartiss-failed-trial-for-cholesterol-drug-leads-to-broad-biopharma-6285267",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-08T14:37:00.000Z",
  "source": {
    "name": "MarketWatch",
    "slug": "marketwatch",
    "url": "https://www.marketwatch.com/story/novartiss-failed-trial-for-cholesterol-drug-leads-to-broad-biopharma-selloff-2d487746?mod=mw_rss_topstories"
  },
  "original_language": "en",
  "account": null,
  "summary": "Along with several other drugmakers, Novartis has bet that lowering Lp(a) will cut the risk of sometimes fatal cardiovascular events.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 6,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: Neuromuscular drug from Novartis fails in key study, adding to pressure on company",
        "url": "https://urgent.news/2026/09/08/stat-neuromuscular-drug-from-novartis-fails-in-key-study-adding-to",
        "published": "2026-09-08T07:28:55.000Z"
      },
      {
        "outlet": "Endpoints News",
        "title": "Novartis sinks after second disastrous trial failure, this time of Avidity-acquired drug",
        "url": "https://urgent.news/2026/09/08/novartis-sinks-after-second-disastrous-trial-failure-this-time-of",
        "published": "2026-09-08T08:24:44.000Z"
      },
      {
        "outlet": "CNBC",
        "title": "Pharma major Novartis falls nearly 10%, heading for worst day on record after three drug trial setbacks",
        "url": "https://urgent.news/2026/09/08/pharma-major-novartis-falls-nearly-10-heading-for-worst-day-on-record",
        "published": "2026-09-08T08:39:10.000Z"
      },
      {
        "outlet": "Yahoo Finance",
        "title": "Novartis twin drug setbacks pile pressure on pipeline and CEO",
        "url": "https://urgent.news/2026/09/08/novartis-twin-drug-setbacks-pile-pressure-on-pipeline-and-ceo",
        "published": "2026-09-08T11:26:06.000Z"
      },
      {
        "outlet": "MarketWatch Top",
        "title": "Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff",
        "url": "https://urgent.news/2026/09/08/novartiss-failed-trial-for-cholesterol-drug-leads-to-broad-biopharma",
        "published": "2026-09-08T14:07:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}